RIGL Market Cap History
Below is a table of the RIGL market cap history going back to 2/23/2010:

Date RIGL Market Cap
2/23/2010390.26M
4/28/2010409.01M
7/29/2010417.02M
10/28/2010428.14M
2/23/2011351.80M
4/28/2011470.64M
7/27/2011624.63M
10/26/2011573.51M
2/29/2012714.42M
4/25/2012564.49M
8/2/2012739.19M
10/31/2012775.17M
2/27/2013582.10M
5/1/2013418.28M
7/31/2013333.11M
10/30/2013274.53M
2/26/2014314.21M
4/30/2014280.10M
7/30/2014299.37M
10/29/2014167.68M
2/25/2015277.34M
5/4/2015400.17M
7/30/2015250.47M
10/29/2015227.51M
2/29/2016205.56M
4/28/2016265.38M
7/27/2016223.23M
10/26/2016255.26M
3/1/2017348.51M
4/26/2017364.85M
7/26/2017310.98M
11/1/2017546.41M
2/27/2018557.54M
3/26/2018552.63M
4/26/2018597.07M
8/2/2018467.71M
11/1/2018491.59M
2/21/2019394.52M
5/1/2019369.50M
8/1/2019382.15M
11/1/2019362.04M
2/20/2020389.40M
5/1/2020288.25M
10/30/2020419.07M
2/23/2021693.77M
4/30/2021633.01M
7/30/2021683.40M
10/29/2021574.58M
2/24/2022424.06M
4/29/2022406.04M
7/29/2022205.68M
10/28/2022126.17M

Also see: RIGL Shares Outstanding History
and RIGL YTD Return
RIGL Historical Market Cap:
-8.52% CAGR
RIGL Historical Market Cap: +-8.52% CAGR

Mouse over chart for data details
2/23/2010 ...10/28/2022
Rigel Pharmaceuticals is a biotechnology company focused on discovering, developing and providing small molecule drugs that improve the lives of patients with hematologic disorders, cancer and rare immune diseases. Co.'s U.S. Food and Drug Administration approved product is TAVALISSE® (fostamatinib disodium hexahydrate) tablets, an oral spleen tyrosine kinase inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The product is also commercially available in Europe, the U.K. (TAVLESSE) and Canada (TAVALISSE) for the treatment of chronic immune thrombocytopenia in adult patients. We show 52 historical shares outstanding datapoints in our RIGL shares outstanding history coverage, used to compute RIGL market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing RIGL market cap history over the course of time is important for investors interested in comparing RIGL's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of RIGL versus a peer is one thing; comparing RIGL market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like RIGL can fluctuate over the course of history. With this page we aim to empower investors researching RIGL by allowing them to research the RIGL market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree RIGL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Rigel Pharmaceuticals (RIGL) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

RLAY Market Cap History
RLMD Market Cap History
RLYB Market Cap History
RMD Market Cap History
RMED Market Cap History
RMTI Market Cap History
RNA Market Cap History
RNAZ Market Cap History
RNXT Market Cap History
RPHM Market Cap History
More Healthcare companies »

 

RIGL Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.